Novo Nordisk Shares Jump 9% in a Week as Buyback, Pill Approval, and Court Win Converge
The Danish pharmaceutical giant has engineered a broad-based recovery, with multiple catalysts aligning to lift its stock. Novo…
Browsing Tag